MAPK1 and colorectal carcinoma: For example, we have shown that in ES-2 ovarian cancer ERK phosphorylation is unchanged (Pin et al., 2018), whereas Penna et al. showed increased ERK in the C26 model of CRC (Penna et al., 2010b).